Worried About Your Global Supply Chain? You Are Not Alone
By Daniel R. Matlis, founder and president, Axendia
Pharmaceutical industry executives are increasingly concerned about the risks posed by long and complex supply chains. Axendia's researchii shows that 78% of industry executives expect global sourcing to increase and 76% anticipate their global manufacturing to grow.
In addition, 70% reported they have key suppliers in China and close to 60% in India. Ninety-four percent of those surveyed reported that contaminated or nonconforming raw materials sourced outside the United States as a top threat.
As a result of outsourcing, many brand owners have lost the ability to collect, act, and capitalize on critical-to-quality indicators and process parameters which can have a significant effect on product safety, efficacy, and quality.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.